Skip to main navigation Skip to search Skip to main content

Acute lung injury associated with 5-fluorouracil and oxaliplatinum combined chemotherapy

  • Rocco Trisolini
  • , L Lazzari Agli
  • , D Tassinari
  • , D Rondelli
  • , Alessandra Cancellieri
  • , M Patelli
  • , F Falcone
  • , V Poletti

Research output: Contribution to journalArticle

Abstract

Diarrhoea, T-CD4+ lymphopenia and bilateral patchy pulmonary infiltrates developed in a male 60 yrs of age, who was treated with oxaliplatinum and 5-fluorouracil for unresectable rectum carcinoma. The findings from transbronchial lung biopsy and bronchoalveolar lavage (BAL) were consistent with an organizing diffuse alveolar damage pattern. Once extensive microbiological studies proved negative, corticosteroids were given and a complete remission of clinical and radiological abnormalities was achieved. It is concluded that the aforementioned pathological manifestations were due to chemotherapy and included a pulmonary adverse reaction, a feature never previously associated with oxaliplatinum and 5-fluorouracil regimens.
Original languageEnglish
Pages (from-to)243-245
Number of pages3
JournalEuropean Respiratory Journal
Volume18
Publication statusPublished - 2001

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Acute lung injury

Fingerprint

Dive into the research topics of 'Acute lung injury associated with 5-fluorouracil and oxaliplatinum combined chemotherapy'. Together they form a unique fingerprint.

Cite this